CSIMarket
 


Kempharm Inc  (KMPH)
Other Ticker:  
 

Cumulative Kempharm Inc's Leverage Ratio for Trailing Twelve Months Period

KMPH's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

KMPH Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Growth -28.8 % -24.05 % 44.21 % - -
Y / Y Total Liabilities Growth 405.04 % 221.16 % -34.15 % -92.93 % -93.03 %
Leverage Ratio for Trailing Twelve Months Period 0.14 0.08 0.04 0.05 0.34
Total Ranking # 315 # 219 # 102 # 145 # 789
Seq. Equity Growth -5.48 % -18.33 % -4.42 % -3.51 % 0.82 %
Seq. Total Liabilities Growth 2.93 % 549.83 % -29.56 % 7.2 % -34.55 %


Leverage Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to net new borrowings of 2.93%, Leverage Ratio for Trailing Twelve Months Period improved to 0.14, below Kempharm Inc's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 113 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Kempharm Inc. While Leverage Ratio for Trailing Twelve Months Period total ranking has deteriorated compare to previous quarter from 219 to 315.

What is Leverage Ratio?
Who are KMPH's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 114
Sector # 183
S&P 500 # 314


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
1.92 0.43 0.05
(Jun 30 2021)  




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Inventiva S a   0.37 
Hutchmed china Limited  0.37 
Regulus Therapeutics Inc.  0.36 
Summit Therapeutics Inc   0.36 
Concert Pharmaceuticals Inc   0.36 
Pardes Biosciences Inc   0.36 
Celsion Corporation  0.35 
Ampio Pharmaceuticals inc   0.35 
Equillium Inc   0.35 
Cue Biopharma Inc   0.35 
Lftd Partners Inc   0.35 
Context Therapeutics Inc   0.34 
Acadia Pharmaceuticals Inc   0.34 
89bio Inc   0.34 
Liquidia Corporation  0.34 
Addex Therapeutics Ltd  0.33 
Repare Therapeutics Inc   0.33 
Actinium Pharmaceuticals Inc   0.33 
Cincor Pharma Inc   0.33 
F star Therapeutics Inc   0.33 
Prothena Corporation Public Limited Company  0.33 
Angion Biomedica Corp  0.32 
Arbutus Biopharma Corp  0.32 
Bellerophon Therapeutics inc  0.32 
Lexicon Pharmaceuticals Inc   0.32 
Xortx Therapeutics Inc   0.32 
Applied Molecular Transport Inc   0.31 
Vyne Therapeutics Inc   0.31 
Qilian International Holding Group Limited  0.31 
Vertex Pharmaceuticals Inc  0.31 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HLTK's Profile

Stock Price

HLTK's Financials

Business Description

Fundamentals

Charts & Quotes

HLTK's News

Suppliers

HLTK's Competitors

Customers & Markets

Economic Indicators

HLTK's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071